Education and training to improve asthma control with a new inhaler
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests whether personalized education about your asthma and how to use the Foster Nexthaler inhaler improves your symptoms. It aims to help people whose asthma is not well controlled despite their current medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a doctor's diagnosis of asthma (based on standard guidelines).
- Your asthma is not well controlled despite using a daily maintenance inhaler.
- You are eligible to use the Foster Nexthaler 100/6 inhaler and have recently switched to it (within the past week or on the day you join).
- You can perform a breathing test (spirometry) and have had one as part of your usual care.
- You can learn how to use the Foster Nexthaler correctly after training.
- You are not currently taking certain other asthma treatments (e.g., biologic injections or continuous oxygen therapy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to improve how we diagnose and treat asthma in children. It tests whether a personalized approach can help children whose asthma is not well controlled with current inhaler treatments.
This trial studies new technologies to help doctors diagnose asthma and better understand airway inflammation. It may help you (or healthy volunteers, if eligible) by allowing your breathing tests and inflammation markers to be measured with newer diagnostic tools.
This trial tests whether a new combination inhaler works as well as a commonly used one for teenagers with asthma that is not well controlled. It aims to find a safe and effective treatment option for adolescents.
This study tests a program that combines exercise and other support to help people with difficult-to-control asthma feel better and be more active. It aims to improve your symptoms and quality of life.
This study tests whether switching to a higher-dose or extrafine triple inhaler helps people whose asthma is still uncontrolled on their current medium-dose combination inhaler. It focuses on improving small-airway function, which may lead to better symptom control.
This study is testing whether an investigational drug called GSK5784283 can improve asthma control compared to a placebo. It is for people with uncontrolled asthma who are already on standard daily asthma medications.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.